Lupus & antiphospholipid syndrome

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) “Damage” working group report on strengths and limitations

Semin Arthritis RheumPublished Cross-sectional study

Authors' conclusion

Approximately 60% of respondents were satisfied with DIAPS and its definitions; however, our survey demonstrated that there is substantial room to improve the current damage index for APS.

Study context

Population
APS ACTION members surveyed on satisfaction with the DIAPS scoring system and individual items58.3% of members
Participants
42 members
Outcome
Satisfaction with the current DIAPS scoring system
Methodological detailssurvey, working group report
  • Survey
  • Working group report

Main finding

As reported in the abstract

Satisfaction with current DIAPS scoring system

Satisfied

26

61.9%

Neutral

4

9.5%

Dissatisfied

12

28.6%

Observational data: associations, not effects.

Further findings

Items with level of agreement (LoA) <75% regarding inclusion in DIAPS (disagreement)

Items with LoA <75%
15 (39.5%)

Recommendations developed by APS ACTION "Damage" Working Group

Recommendations for next generation DIAPS
7
Main categories of respondents' comments
6

Original publication

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) “Damage” working group report on strengths and limitations. Semin Arthritis Rheum. Published 4 December 2024. doi:10.1016/j.semarthrit.2024.152605

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.